Detalhe da pesquisa
1.
Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody-drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study.
Lancet Oncol
; 25(3): 388-399, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38423051
2.
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Cancer
; 129(7): 992-1004, 2023 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36692409
3.
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front-line with paediatric-inspired regimens: A retrospective multicentre Campus ALL study.
Br J Haematol
; 200(4): 440-450, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36335916
4.
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study.
Ann Hematol
; 102(5): 1099-1109, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36959485
5.
Hematological disorders after salvage PARPi treatment for ovarian cancer: Cytogenetic and molecular defects and clinical outcomes.
Int J Cancer
; 151(10): 1791-1803, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35695283
6.
Clinical presentation, diagnosis and management of therapy-related hematological disorders in women with epithelial ovarian cancer treated with chemotherapy and poly-ADP-ribose polymerase inhibitors: A single-center experience.
Int J Cancer
; 148(1): 170-177, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32856727
7.
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Haematologica
; 106(10): 2578-2587, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32855275
8.
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study.
Haematologica
; 109(3): 988-993, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37794811
9.
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
Hematol Oncol
; 37(4): 447-455, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31385337
10.
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 23(12): 2070-2078, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28712935
11.
Factors affecting successful mobilization with plerixafor: an Italian prospective survey in 215 patients with multiple myeloma and lymphoma.
Transfusion
; 54(2): 331-9, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23781769
12.
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.
Front Oncol
; 14: 1367393, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38444680
13.
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma.
Virchows Arch
; 2024 May 23.
Artigo
Inglês
| MEDLINE | ID: mdl-38780617
14.
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination-Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda.
Cancers (Basel)
; 16(2)2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38254875
15.
Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.
Haematologica
; 98(2): 239-46, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23065521
16.
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).
Am J Hematol
; 93(2): E54-E57, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29164738
17.
Improved efficiency of daratumumab treatment of multiple myeloma adopting the subcutaneous route: A micro-costing analysis in three Italian hematology centers.
Cancer Med
; 12(23): 21480-21489, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37942566
18.
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
Cancers (Basel)
; 15(18)2023 Sep 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37760592
19.
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy).
Am J Hematol
; 92(12): E656-E659, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28891226
20.
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
Cancers (Basel)
; 14(12)2022 Jun 18.
Artigo
Inglês
| MEDLINE | ID: mdl-35740677